nocodazole has been researched along with Cancer of Ovary in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Santibáñez, M | 1 |
| Gallardo, D | 1 |
| Morales, F | 1 |
| López, A | 1 |
| Prada, D | 1 |
| Mendoza, J | 1 |
| Castro, C | 1 |
| de León, DC | 1 |
| Oñate, LF | 1 |
| Perez, D | 1 |
| Mohar, A | 1 |
| Herrera, LA | 1 |
| Wang, Q | 1 |
| Moyret-Lalle, C | 1 |
| Couzon, F | 1 |
| Surbiguet-Clippe, C | 1 |
| Saurin, JC | 1 |
| Lorca, T | 1 |
| Navarro, C | 1 |
| Puisieux, A | 1 |
| McKay, TR | 1 |
| Bell, S | 1 |
| Tenev, T | 1 |
| Stoll, V | 1 |
| Lopes, R | 1 |
| Lemoine, NR | 1 |
| McNeish, IA | 1 |
| Lee, EA | 1 |
| Keutmann, MK | 1 |
| Dowling, ML | 1 |
| Harris, E | 1 |
| Chan, G | 1 |
| Kao, GD | 1 |
| Ding, M | 1 |
| Robinson, JM | 1 |
| Behrens, BC | 1 |
| Vandré, DD | 1 |
5 other studies available for nocodazole and Cancer of Ovary
| Article | Year |
|---|---|
The MAD1 1673 G → A polymorphism alters the function of the mitotic spindle assembly checkpoint and is associated with a worse response to induction chemotherapy and sensitivity to treatment in patients with advanced epithelial ovarian cancer.
Topics: Biomarkers, Pharmacological; Calcium-Binding Proteins; Carcinoma, Ovarian Epithelial; Cell Cycle Pro | 2013 |
Alterations of anaphase-promoting complex genes in human colon cancer cells.
Topics: Anaphase-Promoting Complex-Cyclosome; Antineoplastic Agents; Apc3 Subunit, Anaphase-Promoting Comple | 2003 |
Procaspase 3 expression in ovarian carcinoma cells increases survivin transcription which can be countered with a dominant-negative mutant, survivin T34A; a combination gene therapy strategy.
Topics: Adenoviridae; Animals; Apoptosis; Carcinoma; Caspase 3; Caspase 9; Caspases; Cell Cycle; Drug Screen | 2003 |
Inactivation of the mitotic checkpoint as a determinant of the efficacy of microtubule-targeted drugs in killing human cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; CDC2 Protein Kinase; Cell Cycle Proteins; Cell | 2004 |
The microtubule cytoskeleton in human phagocytic leukocytes is a highly dynamic structure.
Topics: Drug-Related Side Effects and Adverse Reactions; Eosinophils; Female; Fluorescent Antibody Technique | 1995 |